SS Innovations International (SSII) Competitors $6.99 -0.55 (-7.29%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock SSII vs. GKOS, IRTC, BLCO, TMDX, SLNO, NVST, LIVN, WRBY, INSP, and LQDAShould you be buying SS Innovations International stock or one of its competitors? The main competitors of SS Innovations International include Glaukos (GKOS), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), and Liquidia Technologies (LQDA). These companies are all part of the "medical equipment" industry. SS Innovations International vs. Its Competitors Glaukos iRhythm Technologies Bausch + Lomb TransMedics Group Soleno Therapeutics Envista LivaNova Warby Parker Inspire Medical Systems Liquidia Technologies Glaukos (NYSE:GKOS) and SS Innovations International (NASDAQ:SSII) are both medical equipment companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership. Do insiders & institutionals hold more shares of GKOS or SSII? 99.0% of Glaukos shares are owned by institutional investors. 5.8% of Glaukos shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts recommend GKOS or SSII? Glaukos currently has a consensus price target of $127.42, suggesting a potential upside of 35.25%. Given Glaukos' stronger consensus rating and higher probable upside, equities research analysts clearly believe Glaukos is more favorable than SS Innovations International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Glaukos 1 Sell rating(s) 2 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 2.79SS Innovations International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is GKOS or SSII more profitable? Glaukos has a net margin of -21.43% compared to SS Innovations International's net margin of -40.20%. Glaukos' return on equity of -8.59% beat SS Innovations International's return on equity.Company Net Margins Return on Equity Return on Assets Glaukos-21.43% -8.59% -6.61% SS Innovations International -40.20%-40.41%-20.80% Which has better earnings & valuation, GKOS or SSII? SS Innovations International has lower revenue, but higher earnings than Glaukos. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlaukos$383.48M14.09-$146.37M-$1.65-57.10SS Innovations International$20.65M65.53-$19.15MN/AN/A Does the media refer more to GKOS or SSII? In the previous week, Glaukos had 10 more articles in the media than SS Innovations International. MarketBeat recorded 12 mentions for Glaukos and 2 mentions for SS Innovations International. Glaukos' average media sentiment score of 1.61 beat SS Innovations International's score of 0.77 indicating that Glaukos is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Glaukos 11 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SS Innovations International 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryGlaukos beats SS Innovations International on 12 of the 14 factors compared between the two stocks. Get SS Innovations International News Delivered to You Automatically Sign up to receive the latest news and ratings for SSII and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SSII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SSII vs. The Competition Export to ExcelMetricSS Innovations InternationalTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$1.35B$2.67B$24.41B$9.73BDividend YieldN/A1.60%2.81%4.09%P/E RatioN/A23.1728.4525.96Price / Sales65.5336.8938.83122.97Price / CashN/A41.7725.8458.38Price / Book31.776.575.926.39Net Income-$19.15M$34.55M$197.30M$265.56M7 Day Performance4.48%2.18%1.51%1.98%1 Month Performance-17.28%-3.56%-1.45%1.33%1 Year PerformanceN/A36.99%33.53%21.15% SS Innovations International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SSIISS Innovations InternationalN/A$6.99-7.3%N/AN/A$1.35B$20.65M0.004GKOSGlaukos4.7654 of 5 stars$89.92-1.3%$127.42+41.7%-30.9%$5.22B$383.48M-54.50780Positive NewsIRTCiRhythm Technologies1.5165 of 5 stars$160.58-0.9%$157.30-2.0%+135.9%$5.21B$591.84M-54.812,000News CoverageAnalyst ForecastBLCOBausch + Lomb2.2558 of 5 stars$14.52+3.1%$15.56+7.1%-10.1%$4.98B$4.79B-18.6213,500Positive NewsTMDXTransMedics Group2.8744 of 5 stars$127.55-1.7%$123.00-3.6%-31.3%$4.42B$441.54M66.09210Positive NewsSLNOSoleno Therapeutics4.5809 of 5 stars$71.63-7.4%$113.30+58.2%+34.6%$4.11BN/A-17.3030News CoverageAnalyst ForecastAnalyst RevisionHigh Trading VolumeNVSTEnvista3.8535 of 5 stars$20.66-0.8%$20.92+1.3%+13.5%$3.46B$2.51B64.5612,300LIVNLivaNova1.7935 of 5 stars$53.72-0.8%$59.29+10.4%+14.2%$2.96B$1.25B-13.812,900Positive NewsAnalyst ForecastWRBYWarby Parker2.2898 of 5 stars$27.24+1.5%$24.06-11.7%+85.6%$2.82B$771.32M-389.093,780Positive NewsINSPInspire Medical Systems4.9406 of 5 stars$87.67+3.7%$165.62+88.9%-51.0%$2.50B$802.80M50.681,246Positive NewsShort Interest ↓LQDALiquidia Technologies3.573 of 5 stars$25.95-0.5%$31.40+21.0%+173.5%$2.25B$14M-15.2650 Related Companies and Tools Related Companies Glaukos Alternatives iRhythm Technologies Alternatives Bausch + Lomb Alternatives TransMedics Group Alternatives Soleno Therapeutics Alternatives Envista Alternatives LivaNova Alternatives Warby Parker Alternatives Inspire Medical Systems Alternatives Liquidia Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SSII) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SS Innovations International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SS Innovations International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access